PeptidePedia The community reference

Talk:Baseline laboratory panel

Discussion page·2 threads·no archives

This article is within the scope of the clinical practice working group.

This is the discussion page for the article Baseline laboratory panel. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Table is not a recommendationResolved

A list of analytes reads as a recommended panel unless it says otherwise. The sentence after the table does that and must stay adjacent to it. — PanelPlannerPam (talk) 09:50, 11 March 2026 (UTC)

Agreed. The article describes a practice rather than prescribing one. ✓ Done — NPOV_Nadia (talk) 13:25, 11 March 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Regression to the meanDone

Including regression to the mean here is unusual and useful — it is the reason a single abnormal value followed by a normal one proves nothing. — PlainNumbersPip (talk) 10:30, 18 June 2026 (UTC)

Same phenomenon as in the placebo-arm discussion, applied to an individual rather than a trial arm. ✓ Done — LabRangeLindy (talk) 14:05, 18 June 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.
This page was last edited on 18 June 2026, by LabRangeLindy. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).